SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 79.96+3.0%Nov 24 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cavan who wrote (906)4/9/2005 12:35:03 AM
From: Jibacoa  Read Replies (2) of 3722
 
Cavan,

Re:GNBT

The stock has been up for 5 days on a roll (It started April on the right foot.<g>)

The stock is apparently responding to the news that it has filed a patent application with the US PTO for its oral/buccal metformin, for use on diabetic patients and its previous announcement that its subsidiary (Antigen Express) has started a PI to evaluate its vaccine on 16 to 24 breast cancer patients with positiveHer-2/neu

The stock traded for a while in the early afternoon today above the resistance from its Feb.2 H at $0.77 but closed a penny below that level. The next resistance is the Jan.4 H at $0.98 before it can try to test the Oct.25 H at $1.04 or the Sep.15 H at $1.25, which is more important.

The stock still remains on the down-trend coming from its June.04 H at 1.86 The nearest important support is now at the $0.70 level.

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext